Literature DB >> 24415636

Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.

Claudia Vellozzi1, Shahed Iqbal, Karen Broder.   

Abstract

Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis worldwide, and is thought to be immune-mediated. It is preceded by upper respiratory or gastrointestinal infection in about two-thirds of cases and is associated with some viral infections, including influenza. GBS has also been associated with the 1976 swine-influenza vaccine. Thereafter, some studies have shown a small increased risk of GBS following receipt of seasonal and 2009 H1N1 monovalent influenza vaccines. Studies over the years have also shown an increased risk of GBS following influenza infection, and the magnitude of risk is several times greater than that following influenza vaccination. Because GBS is rare, and even rarer following vaccination, it is difficult to estimate precise risk. We try to shed light on the complex relationship of GBS and its association with influenza and influenza vaccines over the past 35 years.

Entities:  

Keywords:  Guillain-Barré syndrome; influenza; influenza vaccination

Mesh:

Substances:

Year:  2014        PMID: 24415636     DOI: 10.1093/cid/ciu005

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  54 in total

1.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Authors:  Christian Hoppe; Patrick Obermeier; Susann Muehlhans; Maren Alchikh; Lea Seeber; Franziska Tief; Katharina Karsch; Xi Chen; Sindy Boettcher; Sabine Diedrich; Tim Conrad; Bron Kisler; Barbara Rath
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 3.  Deaths following vaccination: What does the evidence show?

Authors:  Elaine R Miller; Pedro L Moro; Maria Cano; Tom T Shimabukuro
Journal:  Vaccine       Date:  2015-05-23       Impact factor: 3.641

4.  Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Authors:  Sara Ghaderi; Nina Gunnes; Inger Johanne Bakken; Per Magnus; Lill Trogstad; Siri Eldevik Håberg
Journal:  Eur J Epidemiol       Date:  2015-05-26       Impact factor: 8.082

Review 5.  [Postvaccinal complications and management of suspected cases].

Authors:  Doris Oberle; Dirk Mentzer; Fabia Rocha; Renz Streit; Karin Weißer; Brigitte Keller-Stanislawski
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

6.  Localization Analysis of Heterophilic Antigen Epitopes of H1N1 Influenza Virus Hemagglutinin.

Authors:  Chun-Yan Guo; Hai-Xiang Zhang; Jun-Jun Zhang; Li-Jun Sun; Hui-Jin Li; Dao-Yan Liang; Qing Feng; Yan Li; Yang-Meng Feng; Xin Xie; Jun Hu
Journal:  Virol Sin       Date:  2019-04-24       Impact factor: 4.327

7.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

8.  Vaccine Safety Resources for Nurses.

Authors:  Elaine R Miller; Tom T Shimabukuro; Beth F Hibbs; Pedro L Moro; Karen R Broder; Claudia Vellozzi
Journal:  Am J Nurs       Date:  2015-08       Impact factor: 2.220

Review 9.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

Review 10.  Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.

Authors:  Lina Palaiodimou; Maria-Ioanna Stefanou; Aristeidis H Katsanos; Paraskevi C Fragkou; Marianna Papadopoulou; Christos Moschovos; Ioannis Michopoulos; Panagiotis Kokotis; Christos Bakirtzis; Androniki Naska; Theodoros I Vassilakopoulos; Elisabeth Chroni; Sotirios Tsiodras; Georgios Tsivgoulis
Journal:  Eur J Neurol       Date:  2021-04-28       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.